Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Not yet recruiting · NCT06153394 · Registry updated 2024-04-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prolonged Hypercoagulability Following Major Liver Resection for Malignancy | Digestive System Diseases, Embolism and Thrombosis, Hemic and Lymphatic Diseases, cardiovascular disorder, hematologic disorder, liver disorder, thrombophilia, thrombotic disease, vascular disorder | Not yet recruiting | Phase 3 | 2024-04-23 | NCT06153394 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Valeo Pharma Inc | 1 |
| Western University, Canada | 70 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| London Health Sciences Centre | London | Canada | 28 |